The potential of preoperative radiochemotherapy in combined treatment of cervical carcinoma T1B-2ABN0-1M0 has been investigated. The use of cisplatin raised the feasibility of radical surgery from 69 to 87%, as compared with radiation alone, and increased 2-year overall and relapse-free survival to 92.6% and 89.4% vis-a-vis 80.8% and 77.8%, respectively. No increase in complication rates in the blood, rectum or bladder during or shortly after treatment was reported.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[assessment effectiveness
4
effectiveness preoperative
4
preoperative chemoradiotherapy
4
chemoradiotherapy patients
4
patients t1b-2abn0-1m0
4
t1b-2abn0-1m0 cervical
4
cervical cancer]
4
cancer] potential
4
potential preoperative
4
preoperative radiochemotherapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!